Medtronic Bets On Twelve In Transcatheter Mitral Valve Replacement Race

The medtech giant is acquiring Twelve Inc. to expand its early-stage efforts in transcatheter mitral valve replacement.

The race to develop the best transcatheter mitral replacement valve technology continues to heat-up with Medtronic PLC's $458 million acquisition of Twelve, Inc.

Medtronic will pay $408 million up-front for privately held Twelve, plus another $50 million when a transcatheter mitral valve based...

More from Strategy

More from Business